Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KROS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
KROS
Keros Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
KROS
Keros Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KROS, solid
LLY, dashed
KROS
Keros Therapeutics, Inc.
Change
9.31
▼
−1.50%
· post 9.31
Mkt cap
$185.5M
Revenue
$40M
Q3 FY26
Revenue
$244M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
KROS
Keros Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
9.31
▼
−1.50%
post 9.31
Price
1,360.90
▼
−0.28%
post 1,358.90
$185.5M
Mkt cap
$1.2T
Q3 FY26
$40M
Revenue
$24.4B
Q3 FY26
FY25
$244M
Revenue
$65.2B
FY25
Change
Change
KROS
9.31
▼
−1.50%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26